Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
Cost-benefit analysis of a pharmacist-advocated pneumococcal vaccination program
Autore:
Joish, VN; Limcangco, RMT; Armstrong, EP;
Indirizzi:
Univ Arizona, Coll Pharm, Tucson, AZ 85721 USA Univ Arizona Tucson AZ USA85721 rizona, Coll Pharm, Tucson, AZ 85721 USA
Titolo Testata:
FORMULARY
fascicolo: 2, volume: 36, anno: 2001,
pagine: 147 -
SICI:
1082-801X(200102)36:2<147:CAOAPP>2.0.ZU;2-5
Fonte:
ISI
Lingua:
ENG
Soggetto:
INFLUENZA VACCINATION; IMMUNIZATION; TRIAL; PNEUMONIA; EFFICACY; ADULTS; RISK;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Clinical Medicine
Citazioni:
20
Recensione:
Indirizzi per estratti:
Indirizzo: Joish, VN Univ Arizona, Coll Pharm, Tucson, AZ 85721 USA Univ Arizona Tucson AZ USA 85721 ll Pharm, Tucson, AZ 85721 USA
Citazione:
V.N. Joish et al., "Cost-benefit analysis of a pharmacist-advocated pneumococcal vaccination program", FORMULARY, 36(2), 2001, pp. 147

Abstract

Pharmacists are increasingly taking on immunization roles in their communities as advocates, facilitators, and immunizers. Between 50% and 94% of people who receive a pharmacist's recommendation to be immunized accept that recommendation. Pneumococcal diseases impose a heavy burden on the health ofadults in developed and developing countries. There are sound reasons for believing that much of this burden could be reduced by widespread use of the current pneumococcal vaccine. This month's column presents a cost-benefitanalysis, using both published and hypothetical figures, to compare a traditional pneumococcal vaccination program with one that uses pharmacists as advocates for pneumococcal vaccination.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 06/04/20 alle ore 01:52:45